Doxazosin Mesylate Structural Formula (426f6918 7705 4988 A875 823196f43859 01)
Doxazosin
Product Images NDC 42254-075
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 42254-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Study 2 Maximum Flow Rate (426f6918 7705 4988 A875 823196f43859 02)
This text appears to describe the results of "Study 2" that looked at the maximum flow rate and symptom score for a placebo and two doses (4mg and 8mg) of a medication. However, the meaning and context of these numbers cannot be fully determined without additional information on the study and medication.*
Figure 1 (Study 1)
The text appears to be a table describing the mean increase in maximum urinary flow rate and mean change in total symptom score from baseline for a duration of treatment in weeks for a placebo and a drug called Doxazosin. The table includes numerical values for each category and specifies the significance levels for the data compared to placebo and baseline. The drug was titrated up to a maximum of 8 mg.*
Doxazosin 2mg (426f6918 7705 4988 A875 823196f43859 04)
This is a description of a medication called Doxazosin 2mg. It is packaged in a bottle with 30 tablets, and the product ID is QD007530CA. The medication is manufactured by Novopharm Limited in Toronto, Canada. The pills are white and capsule-shaped. The package should be stored at a controlled room temperature between 15°C-30°C. The medication is only available through a prescription from a physician.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
